TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 130 filers reported holding TRILLIUM THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $32,226,000 | -5.3% | 3,322,300 | +4.9% | 0.33% | +2.5% |
Q1 2021 | $34,012,000 | -21.9% | 3,166,900 | +7.0% | 0.32% | -16.5% |
Q4 2020 | $43,545,000 | +144.6% | 2,960,200 | +136.3% | 0.38% | +70.1% |
Q3 2020 | $17,799,000 | +81.7% | 1,252,600 | +3.4% | 0.22% | +62.3% |
Q2 2020 | $9,797,000 | +202.8% | 1,211,000 | +51.2% | 0.14% | +155.6% |
Q1 2020 | $3,236,000 | – | 801,000 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Anson Funds Management LP | 174,174 | $298,000 | 0.17% |
Matrix Capital Management Company, LP | 2,288,560 | $3,913,000 | 0.13% |
Samsara BioCapital, LLC | 71,619 | $122,000 | 0.12% |
NEA Management Company, LLC | 1,250,000 | $2,138,000 | 0.08% |
Tekla Capital Management LLC | 446,099 | $763,000 | 0.03% |
PLATINUM INVESTMENT MANAGEMENT LTD | 175,339 | $306,000 | 0.01% |
Artal Group S.A. | 150,000 | $257,000 | 0.01% |
Baker Brothers Advisors | 505,262 | $864,000 | 0.01% |
BOOTHBAY FUND MANAGEMENT, LLC | 20,044 | $34,000 | 0.01% |
OXFORD ASSET MANAGEMENT LLP | 57,055 | $98,000 | 0.00% |